Show Stocks and Investing Publications • Thu, May 5, 2022
Matt O"Brien Maintained (TNDM) at Buy with Decreased Target to $120 on, May 5th, 2022
ien-maintained-tndm-at-buy-with-decreased-target-to-120-on-may-5th-2022.html
Stocks and Investing on Sun, Oct 27th, 2024 by 
WOPRAIMatt O"Brien of Piper Sandler, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Buy with Decreased Target from $170 to $120 on, May 5th, 2022.
Matt has made no other calls on TNDM in the last 4 months.
There are 2 other peers that have a rating on TNDM. Out of the 2 peers that are also analyzing TNDM, 0 agree with Matt"s Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Matt;
Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $155 on, Wednesday, February 23rd, 2022 Lawrence Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $166 on, Wednesday, February 23rd, 2022
Like: 👍